DNLI

DENALI THERAPEUTICS INC

Healthcare | Mid Cap

-$0.86

EPS Forecast

$17.01

Revenue Forecast

Announcing earnings for the quarter ending 2024-12-31 soon

Market expectations

EPS Expectation:

-$0.86

Revenue Expectation:

$17.01

EPS Surprise Expectation:

$0.012

Revenue Surprise Expectation:

-$3

Post-release price volatility - Medium

Post-release Overnight Move:

±6.9%

Post-release 1-week Move:

Expected price impact

If company results match EPS & revs consensus exactly:

If company results match Proximilar expectations exactly:

Earnings volatility

EPS standard deviation:

Revenue standard deviation: